Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,45 USD | -2,03% | +3,57% | -17,61% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 71,11 mln. 66,5 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -33 mln. -30,86 mln. | Nettowinst (verlies) 2025 * | -45 mln. -42,09 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,54
x | K/w-verhouding 2025 * |
-2,3
x | Werknemers | 28 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 89,43% |
Recentste transcriptie over Corvus Pharmaceuticals, Inc.
1 dag | -2,03% | ||
1 week | +3,57% | ||
Lopende maand | -18,54% | ||
1 maand | -17,61% | ||
3 maanden | -29,27% | ||
6 maanden | +26,09% | ||
Lopend jaar | -17,61% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27-01-14 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 27-01-14 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27-01-14 |
Ian Clark
BRD | Director/Board Member | 62 | 03-01-17 |
Terry Gould
BRD | Director/Board Member | 67 | 01-11-14 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,45 | -2,03% | 124 494 |
25-04-24 | 1,48 | -1,99% | 66 282 |
24-04-24 | 1,51 | -1,31% | 90 571 |
23-04-24 | 1,53 | +6,25% | 137 350 |
22-04-24 | 1,44 | +2,86% | 130 642 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-17,61% | 71,11 mln. | |
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |